Login / Signup

Cost-effectiveness of toripalimab plus chemotherapy for advanced esophageal squamous cell carcinoma.

Kai XuHong WuChongchong ZhouYuwen BaoMin YuLingli ZhangXin Li
Published in: International journal of clinical pharmacy (2023)
Adding toripalimab to chemotherapy was not cost-effective in patients with advanced ESCC in China.
Keyphrases
  • locally advanced
  • squamous cell carcinoma
  • rectal cancer
  • chemotherapy induced
  • radiation therapy